LOVD FANCD1 homepage

General information
Gene name Fanconi anemia, complementation group D1 (BRCA2)
Gene symbol FANCD1
Chromosome Location 13q12.3
Database location chromium.liacs.nl
Curator Arleen Auerbach
PubMed references View all (unique) PubMed references in the FANCD1 database
Date of creation February 10, 2005
Last update October 09, 2014
Version FANCD1 141009
Add sequence variant Submit a sequence variant
First time submitters Register here
Total number of unique DNA variants reported 0
Total number of individuals with variant(s) 0
Total number of variants reported 0
Subscribe to updates of this gene
NOTE NOTE: all variants have been moved to the LOVD v3 BRCA2 (FANCD1) database

Graphical displays and utilities
Summary tables Summary of all sequence variants in the FANCD1 database, sorted by type of variant (with graphical displays and statistics)

Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2015. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.